Podnos Yale
- SEC CIK
- 0001891104
In the past year, 2 open-market sale filings worth $276.5K and no purchases.
Current role at each company
- DFPH Starling Oncology, Inc.Chief Medical Officeras of Jul 16, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $276.5K
- 2 filings
- Net
- −$276.5K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Podnos Yale as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 16, 2026 (view filing)8:05 PM ET | Jul 14 | 2 days | Podnos YaleChief Medical Officer | SSale | −23.5K | $6.41 | −$150.3K | −8.3%259.5K after | 2 lots10b5-1 |
| Jun 9, 2026 (view filing) | Jun 8 | 1 day | Podnos YaleChief Medical Officer | SSale | −23.5K | $5.38 | −$126.2K | −8.3%259.5K after | 10b5-1 |
| Mar 28, 2025 (view filing)5:48 PM ET | Mar 26 | 2 days | Podnos YaleChief Medical Officer | PPurchase | +9.06K | $1.04 | +$9.43K | +12.9%79.0K after | |
| Mar 28, 2025 (view filing)5:48 PM ET | Mar 26 | 2 days | Podnos YaleChief Medical Officer | PPurchase | +4.53K | $0.125 | +$566 | –4.53K after | Derivative |
| Nov 22, 2022 (view filing) | Nov 15 | 7 days | Podnos YaleChief Medical Officer | SSale | −199 | $2.03 | −$403.97 | −0.5%43.1K after | Amended |